Ruhong Li

Ruhong Li

Auto-generated profile, based on publicly available information

Ruhong Li

Department of General Surgery, Yan’An Hospital Affiliated to Kunming Medical University, Kunming, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2021 in Cancer Gene Therapy
Verified
Journal Article
Open access
PDF file
QPQinrong Ping
Qinrong Ping
RYRuping Yan
Ruping Yan
XCXin Cheng
Xin Cheng
WWWenju Wang
Wenju Wang
YZYiming Zhong
Yiming Zhong
RLRuhong Li
Ruhong Li
Tumors are one of the main causes of death in humans. The development of safe and effective methods for early diagnosis and treatment of tumors is a difficult problem that needs to be solved urgently. It is well established that the occurrence of tumors involves complex biological mechanisms, and the tumor microenvironment (TME) plays an important role in regulating the biological behavior of tumors. Cancer-associated fibroblasts (CAFs) are a group of activated fibroblasts with significant heterogeneity and plasticity in the tumor microenvironment. They secrete a variety of active factors to regulate tumor occurrence, development, metastasis, and therapeutic resistance. Although most studies suggest that CAFs have significant tumor-promoting functions, some evidence indicates that they may have certain tumor-suppressive functions in the early stage of tumors. Current research on CAFs continues to face many challenges, and the heterogeneity of their origin, phenotype, and function is a major difficulty and hot spot. To provide new perspectives for the research on CAFs and tumor diagnosis and treatment, this review summarizes the definition, origin, biomarkers, generation mechanism, functions, heterogeneity, plasticity, subpopulations, pre-metastasis niches (PMN), immune microenvironment, and targeted therapy of CAFs, describes the research progress and challenges, and proposes possible future research directions based on existing reports.

28 June 2021 in Cancer Gene Therapy
Verified
Journal Article
Open access
PDF file
QPQinrong Ping
Qinrong Ping
RYRuping Yan
Ruping Yan
XCXin Cheng
Xin Cheng
WWWenju Wang
Wenju Wang
YZYiming Zhong
Yiming Zhong
RLRuhong Li
Ruhong Li